LGMK · As filed with the SEC
LogicMark cash flow statement, by fiscal year
The statement as LogicMark presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Statements of Cash Flows · USD
| USD | FY2025 Year ended Dec 31, 2025 | FY2024 Year ended Dec 31, 2024 | FY2023 Year ended Dec 31, 2023 | FY2022 Year ended Dec 31, 2022 | FY2021 Year ended Dec 31, 2021 | FY2020 Year ended Dec 31, 2020 | FY2019 Year ended Dec 31, 2019 | FY2018 Year ended Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Cash Flows from Operating Activities | ||||||||
| Net loss | — | — | — | — | (11,707,889) | (2,864,984) | — | — |
| Loss from continuing operations | — | — | — | — | — | (2,864,984) | (2,368,418) | (1,328,616) |
| Net loss | (7,467,427) | (9,003,745) | (14,550,609) | (6,924,965) | — | — | (11,789,455) | (7,089,962) |
| (Loss) Income from discontinued operations | — | — | — | — | — | — | — | (5,761,346) |
| Loss from discontinued operations | — | — | — | — | — | — | (3,432,270) | — |
| Loss on sale of discontinued operations | — | — | — | — | — | — | (5,988,767) | — |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Depreciation | 87,609 | 114,643 | 105,674 | 26,888 | 29,208 | 65,847 | 74,092 | 143,939 |
| Stock based compensation | 1,245,198 | 1,636,287 | 1,577,440 | 1,644,269 | 936,957 | 160,000 | 607,705 | 989,679 |
| Amortization of debt discount | — | — | — | — | 137,855 | 106,215 | 217,362 | 85,348 |
| Amortization of intangible assets | 761,796 | 761,796 | 761,796 | 776,793 | 761,815 | 761,815 | 761,815 | 761,815 |
| Change in fair value of contingent consideration | — | — | — | — | — | — | (85,111) | (1,498,922) |
| Non-cash charge for modification of warrant terms | — | — | — | — | — | — | — | 345,280 |
| Loss on extinguishment of debt | — | — | — | — | — | — | 2,343,879 | 68,213 |
| Amortization of deferred debt issuance costs | — | — | — | — | — | — | 656,393 | 291,721 |
| Amortization of product development costs | — | — | — | 15,029 | 713,119 | 549,446 | — | — |
| Non-cash charge for modification of warrant terms | — | — | — | — | 2,881,729 | — | — | — |
| Goodwill impairment | — | — | — | — | 4,521,000 | — | — | — |
| Forgiveness of Paycheck Protection Plan loans and accrued interest | — | — | — | — | (349,176) | — | — | — |
| Deferred taxes | — | — | — | — | 195,576 | — | (365,397) | 29,996 |
| Amortization of product development costs | 436,112 | 328,539 | 53,771 | — | — | — | — | — |
| Amortization of software development costs | 754,962 | 405,449 | 23,354 | — | — | — | — | — |
| Loss on disposal of fixed assets | 2,718 | 1,654 | — | — | — | — | — | — |
| Goodwill impairment | — | — | 7,815,000 | — | — | — | — | — |
| Deferred tax expense | — | — | (320,102) | 124,468 | — | — | — | — |
| Fair value of Series H preferred stock issued to Series B holders | — | 1,523,370 | — | — | — | — | — | — |
| Amortization of operating lease right-of-use assets | 56,527 | — | — | — | — | — | — | — |
| Change in fair value of government securities | (64,361) | — | — | — | — | — | — | — |
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | (1,457) | 9,292 | 388,948 | (303,846) | 34,970 | (95,193) | 208,497 | 135,259 |
| Inventory | (351,342) | 128,493 | 567,755 | (507,931) | (469,929) | 535,928 | (432,766) | (164,191) |
| Prepaid expenses and other current assets | — | — | — | — | (393,638) | (170,058) | 68,454 | 216,692 |
| Prepaid expenses and other current assets | (204,593) | (16,495) | (111,080) | 500,093 | — | — | — | — |
| Accounts payable | (344,880) | (276,625) | 22,193 | 180,621 | (2,256,383) | 658,245 | 787,379 | 362,464 |
| Accrued expenses | 63,123 | (92,619) | (649,620) | 859,294 | (949,135) | (120,220) | (233,762) | (488,866) |
| Total Adjustments | — | — | — | — | 5,793,969 | 2,452,025 | 4,608,540 | 1,278,427 |
| Net Cash (Used in) Provided by Operating Activities of Continuing Operations | — | — | — | — | — | (412,959) | 2,240,122 | (50,189) |
| Deferred revenue | — | 225,195 | — | — | — | — | — | — |
| Deferred revenue | 14,721 | — | — | — | — | — | — | — |
| Other long-term liabilities | (49,044) | — | — | — | — | — | — | — |
| Net Cash Used in Operating Activities | (5,060,338) | (4,254,765) | (4,315,480) | (3,609,287) | (5,913,920) | — | — | — |
| Cash flows from Investing Activities | ||||||||
| Pay down of contingent consideration | — | — | — | — | — | — | (181,065) | (3,156,088) |
| Net proceeds received from sale of discontinued operations | — | — | — | — | — | — | 2,955,170 | — |
| Purchase of equipment | — | — | — | — | — | — | (23,791) | (10,766) |
| Net Cash Provided by Investing Activities of Continuing Operations | — | — | — | — | — | — | 2,750,314 | (3,166,854) |
| Purchase of equipment and website development | — | — | (53,429) | — | — | — | — | — |
| Product development costs | — | — | (562,610) | (1,025,691) | — | — | — | — |
| Purchase of equipment and website development | (71,255) | (25,568) | — | (282,466) | — | — | — | — |
| Product development costs | (232,724) | (435,285) | — | — | — | — | — | — |
| Software development costs | (1,117,307) | (999,708) | (757,396) | — | — | — | — | — |
| Redemption/sale of government securities | 4,582,537 | — | — | — | — | — | — | — |
| Purchase of government securities | (10,461,394) | — | — | — | — | — | — | — |
| Net Cash Used in Investing Activities | (7,300,143) | (1,460,561) | (1,373,435) | (1,308,157) | — | — | — | — |
| Cash flows from Financing Activities | ||||||||
| Proceeds from exercise of common stock warrants | — | — | — | — | — | 1,279,859 | — | 425,000 |
| Pay down of short-term debt | — | — | — | — | — | — | (638,881) | (212,961) |
| Proceeds received in connection with issuance of common stock and warrants, net | — | — | — | — | — | 1,864,528 | 3,214,042 | — |
| Repayment of term debt with Sagard Capital | — | — | — | — | — | — | (16,000,000) | — |
| Revolver borrowings, net | — | — | — | — | — | — | — | (12,000,000) |
| Proceeds received in connection with issuance of Series D preferred stock, net | — | — | — | — | — | 2,000,000 | — | — |
| Term loan borrowings, net of deferred debt issue costs | — | — | — | — | — | — | 14,670,579 | 14,906,030 |
| Proceeds from sale of common stock and warrants | — | — | — | — | 6,835,065 | — | — | — |
| Proceeds received in connection with issuance of Series E preferred stock, net | — | — | — | — | 4,000,003 | — | — | — |
| Proceeds received in connection with issuance of Series F preferred stock, net | — | — | — | — | 3,999,999 | — | — | — |
| Term loan repayment | — | — | — | — | (11,095,877) | (2,212,500) | (3,191,623) | — |
| Proceeds from PPP loan | — | — | — | — | — | 346,390 | — | — |
| Fees paid in connection with equity offerings | — | — | — | — | — | (65,152) | (55,546) | (54,735) |
| Net Cash (Used In) Provided by Financing Activities of Continuing Operations | — | — | — | — | — | — | (2,001,429) | 3,063,334 |
| Proceeds from sale of common stock and warrants | 14,377,835 | 4,492,198 | 5,211,428 | — | 11,834,722 | — | — | — |
| Fees paid in connection with equity offerings | — | — | (1,026,607) | — | — | — | — | — |
| Fees paid in connection with equity offerings | (1,978,929) | (1,210,540) | — | — | (570,492) | — | — | — |
| Common stock withheld to pay taxes | — | (4,235) | — | — | — | — | — | — |
| Warrants exercised for common stock | 22,147 | 146,654 | 1,165,156 | — | — | — | — | — |
| Term loan repayment and termination fee | — | — | — | — | (1,072,500) | — | — | — |
| Series C redeemable preferred stock dividends | (300,000) | (300,000) | (300,000) | (300,000) | (300,000) | — | — | — |
| Net Cash Provided by Financing Activities | 12,121,053 | 3,124,077 | 5,049,977 | (300,000) | 13,630,920 | 3,213,125 | — | — |
| Net Increase in Cash and Restricted Cash from Continuing Operations | — | — | — | — | — | 2,800,166 | 2,989,007 | (153,709) |
| Cash used by operating activities of discontinued operations | — | — | — | — | — | — | (2,844,419) | (3,894,987) |
| Cash used in investing activities of discontinued operations | — | — | — | — | — | — | (21,849) | (13,449) |
| Net Cash Used by Discontinued Operations | — | — | — | — | — | — | (2,866,268) | (3,908,436) |
| Net Increase (Decrease) in Cash and Restricted Cash | — | — | — | — | — | — | 122,739 | (4,062,145) |
| Cash and Restricted Cash - Beginning of Year | — | — | — | — | — | — | 1,614,641 | 5,676,786 |
| Cash and Restricted Cash - End of Year | — | — | — | — | — | — | — | 1,614,641 |
| Net Decrease in Cash and Cash Equivalents | (239,428) | (2,591,249) | (638,938) | (5,217,444) | 7,717,000 | 2,800,166 | — | — |
| Cash and Cash Equivalents - Beginning of Year | 3,806,915 | 6,398,164 | 7,037,102 | 12,254,546 | 4,537,546 | 1,737,380 | 1,614,641 | — |
| Cash and Cash Equivalents - End of Year | 3,567,487 | 3,806,915 | 6,398,164 | 7,037,102 | 12,254,546 | 4,537,546 | 1,737,380 | — |
| Interest | — | — | — | — | 617,336 | 1,619,151 | 2,013,618 | 3,153,450 |
| Taxes | — | — | — | — | 93,313 | 10,014 | 11,359 | 13,843 |
| Taxes | — | 20,579 | 3,152 | — | — | — | — | — |
| Cash paid during the years for: | ||||||||
| Income taxes, net of refunds | ||||||||
| Other | 4,810 | — | — | — | — | — | — | — |
| Total income taxes, net of refunds | 13,810 | — | — | — | — | — | — | — |
| Non-cash investing and financing activities: | ||||||||
| Accrued fees incurred in connection with equity offerings | — | — | — | — | — | 30,424 | 71,968 | 77,590 |
| Common stock issued in connection with management incentive plans | — | — | — | — | — | — | 216,267 | — |
| Common stock issued in connection with management incentive plans | — | — | — | — | — | 200,794 | — | 706,541 |
| Issuance of common stock in connection with conversion of Series D preferred stock | — | — | — | — | — | 2,000,000 | — | — |
| Accrued Series C preferred stock dividends | — | — | — | — | — | 25,000 | 25,000 | 25,000 |
| Accrued preferred stock dividends | — | — | — | 48,389 | 94,933 | — | — | — |
| Common stock issued in connection with management incentive plans | — | — | — | — | 80,456 | — | — | — |
| Common stock issued for dividends | — | — | — | — | 19,584 | — | — | — |
| Conversion of Series E preferred stock to common stock | — | — | — | — | 4,000,003 | — | — | — |
| Conversion of Series F preferred stock to common stock | — | — | 201,000 | — | — | — | — | — |
| Common stock issued for to settle Series F preferred stock dividend | — | — | 48,389 | — | — | — | — | — |
| Conversion of Series F preferred stock to common stock | — | — | — | — | 3,479,999 | — | — | — |
| Website development included in accounts payable | — | — | — | 18,494 | — | — | — | — |
| Product development costs included in accounts payable and accrued expenses | — | — | 113,538 | — | — | — | — | — |
| Product development costs included in accounts payable and accrued expenses | 76,663 | 8,405 | — | — | — | — | — | — |
| Software development costs included in accounts payable and accrued expenses | — | 124,931 | 201,841 | — | — | — | — | — |
| Software development costs included in accounts payable and accrued expenses | 73,474 | — | — | — | — | — | — | — |
| Series H preferred stock conversion to common stock | 472,245 | 1,051,125 | — | — | — | — | — | — |
| Website development included in accounts payable | 20,396 | — | — | — | — | — | — | — |
| Lease liabilities and right-of-use assets arising from lease extension | 331,944 | — | — | — | — | — | — | — |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.